News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Staff September 11, 2023 Post Views: 35 Related Continue Reading Previous Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T RelapseNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 More Stories Healthcare News NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania Staff September 20, 2023 News Izotropic Closes Non-Brokered Private Placement Staff September 20, 2023 News Yada Yoga Extends Wellness Support to Protestors in the Entertainment Industry on the Picket Lines Staff September 20, 2023
